Douglas Vernimmen - Concepedia

Author

Douglas Vernimmen

University of Edinburgh ORCID

Also Known As

D Vernimmen, D. VERNIMMEN, D. Vernimmen, Douglas VERNIMMEN, Douglas Vernimmen

Publications

Citations

H-Index

Concepts

All Affiliations

University of Edinburgh University of Oxford John Radcliffe Hospital Roslin Institute MRC Weatherall Institute of Molecular Medicine

About

Douglas Vernimmen is an author at University of Edinburgh specializing in medicine, gene expression, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	868
2	Natural Sciences	5	5	394
3	Cell Biology	5	5	317
4	Biology	1	1	196
5	Hepatology	1	1	99

Douglas Vernimmen

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia J Paris, Marcos Morgan, Joana Campos, Cell stem cell	2019	542
A Regulatory SNP Causes a Human Genetic Disease by Creating a New Transcriptional Promoter Marco De Gobbi, Vip Viprakasit, Jim R. Hughes, Science	2006	282
Intragenic Enhancers Act as Alternative Promoters Monika S. Kowalczyk, Jim R. Hughes, David Garrick, Molecular Cell Transcriptional RegulationGeneticsTranscription RegulationGene RegulationGene Expression	2012	266
Long‐range chromosomal interactions regulate the timing of the transition between poised and active gene expression Douglas Vernimmen, Marco De Gobbi, Jacqueline A. Sloane-Stanley, The EMBO Journal	2007	239
An interspecies analysis reveals a key role for unmethylated CpG dinucleotides in vertebrate Polycomb complex recruitment Magnus Lynch, Andrew J. H. Smith, Marco De Gobbi, The EMBO Journal BiologyChromatinKey RoleMedicineGenetics	2011	196
Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer Simon P. Newman, Nicholas P Bates, Douglas Vernimmen, Oncogene Systems BiologyBreast OncologyCofactor CompetitionBreast CancerRadiation Oncology	2000	109
The STAT3–IL-10–IL-6 Pathway Is a Novel Regulator of Macrophage Efferocytosis and Phenotypic Conversion in Sterile Liver Injury Lara Campana, Philip J. Starkey Lewis, Antonella Pellicoro, The Journal of Immunology ImmunologyImmune RegulationPathologyCell DeathImmune System	2017	99
Adventitious changes in long-range gene expression caused by polymorphic structural variation and promoter competition Karen M. Lower, Jim R. Hughes, Marco De Gobbi, Proceedings of the National Academy of Sciences Nme4 ExpressionGeneticsGenomic MechanismMolecular BiologyGene Characterization	2009	89
Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers Douglas Vernimmen, Maud Guéders, S Pisvin, British Journal of Cancer	2003	88
Chromosome looping at the human α-globin locus is mediated via the major upstream regulatory element (HS −40) Douglas Vernimmen, Fatima Marques-Kranc, Jacqueline A. Sharpe, Blood	2009	87

Page 1